Drug firms must cut price of pneumonia vaccine, says MSFBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2238 (Published 24 April 2015) Cite this as: BMJ 2015;350:h2238
- Anne Gulland
The global drug companies GlaxoSmithKline and Pfizer are being urged to cut the price of the pneumonia vaccine in poor countries to less than $5 (£3.30; €4.61) a child.
The charity Médecins Sans Frontières has launched a campaign calling on the companies to be transparent about the amount they charge for the vaccine. It said that the lowest price it was aware of was around $10 a dose. The charity also claimed that the firms stop countries disclosing the price they pay for the vaccine.
In January MSF published figures showing that the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial